Neil Korman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Andrew Blauvelt, MD, leads a roundtable discussion with Melinda Gooderham, MSc, MD, and Neil Korman, MD

Andrew Blauvelt, MD, leads a discussion with Melinda Gooderham, MD, MSc, and Neil Korman, MD, PhD

An expert roundtable discussion on guselkumab and risankizumab

Andrew Blauvelt, MD, leads a discussion with Melinda Gooderham, MD, MSc, and Neil Korman, MD, PhD

Results add to the growing body of evidence and reinforce the efficacy profile of Sotyktu, a once-daily, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of moderate-to-severe plaque psoriasisNew analysis to be presented at the 2022 European Academy of Dermatology and Venereology Cong...